215 related articles for article (PubMed ID: 25330220)
1. Crovirin, a snake venom cysteine-rich secretory protein (CRISP) with promising activity against Trypanosomes and Leishmania.
Adade CM; Carvalho AL; Tomaz MA; Costa TF; Godinho JL; Melo PA; Lima AP; Rodrigues JC; Zingali RB; Souto-Padrón T
PLoS Negl Trop Dis; 2014 Oct; 8(10):e3252. PubMed ID: 25330220
[TBL] [Abstract][Full Text] [Related]
2. Effect of Crotalus viridis viridis snake venom on the ultrastructure and intracellular survival of Trypanosoma cruzi.
Adade CM; Cons BL; Melo PA; Souto-Padrón T
Parasitology; 2011 Jan; 138(1):46-58. PubMed ID: 20663246
[TBL] [Abstract][Full Text] [Related]
3. Biphenylquinuclidines as inhibitors of squalene synthase and growth of parasitic protozoa.
Orenes Lorente S; Gómez R; Jiménez C; Cammerer S; Yardley V; de Luca-Fradley K; Croft SL; Ruiz Perez LM; Urbina J; Gonzalez Pacanowska D; Gilbert IH
Bioorg Med Chem; 2005 May; 13(10):3519-29. PubMed ID: 15848765
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of a new series of 3,5-disubstituted isoxazoles active against Trypanosoma cruzi and Leishmania amazonensis.
da Rosa R; de Moraes MH; Zimmermann LA; Schenkel EP; Steindel M; Bernardes LSC
Eur J Med Chem; 2017 Mar; 128():25-35. PubMed ID: 28152426
[TBL] [Abstract][Full Text] [Related]
5. Germacranolide-type sesquiterpene lactones from Smallanthus sonchifolius with promising activity against Leishmania mexicana and Trypanosoma cruzi.
Ulloa JL; Spina R; Casasco A; Petray PB; Martino V; Sosa MA; Frank FM; Muschietti LV
Parasit Vectors; 2017 Nov; 10(1):567. PubMed ID: 29132413
[TBL] [Abstract][Full Text] [Related]
6. The potential effects of new synthetic drugs against Leishmania amazonensis and Trypanosoma cruzi.
Canto-Cavalheiro MM; Echevarria A; Araujo CA; Bravo MF; Santos LH; Jansen AM; Leon LL
Microbios; 1997; 90(362):51-60. PubMed ID: 9301071
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural alterations and growth inhibition of Trypanosoma cruzi and Leishmania major induced by Bothrops jararaca venom.
Gonçalves AR; Soares MJ; de Souza W; DaMatta RA; Alves EW
Parasitol Res; 2002 Jul; 88(7):598-602. PubMed ID: 12107450
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a Binuclear Cyclopalladated Compound Therapy for Cutaneous Leishmaniasis in the Murine Model of Infection with Leishmania amazonensis and Its Inhibitory Effect on Topoisomerase 1B.
Velásquez AMA; Ribeiro WC; Venn V; Castelli S; Camargo MS; de Assis RP; de Souza RA; Ribeiro AR; Passalacqua TG; da Rosa JA; Baviera AM; Mauro AE; Desideri A; Almeida-Amaral EE; Graminha MAS
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28507113
[TBL] [Abstract][Full Text] [Related]
9. Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasis.
Lorente SO; Rodrigues JC; Jiménez Jiménez C; Joyce-Menekse M; Rodrigues C; Croft SL; Yardley V; de Luca-Fradley K; Ruiz-Pérez LM; Urbina J; de Souza W; González Pacanowska D; Gilbert IH
Antimicrob Agents Chemother; 2004 Aug; 48(8):2937-50. PubMed ID: 15273104
[TBL] [Abstract][Full Text] [Related]
10. Furan derivatives impair proliferation and affect ultrastructural organization of Trypanosoma cruzi and Leishmania amazonensis.
Zuma AA; Teixeira de Macedo-Silva S; Achari A; Vinayagam J; Bhattacharjee P; Chatterjee S; Gupta VK; Cristina de Sousa Leite A; Souza de Castro L; Jaisankar P; de Souza W
Exp Parasitol; 2021 May; 224():108100. PubMed ID: 33744229
[TBL] [Abstract][Full Text] [Related]
11. Antiprotozoal activity of 1-phenethyl-4-aminopiperidine derivatives.
Dardonville C; Fernández-Fernández C; Gibbons SL; Jagerovic N; Nieto L; Ryan G; Kaiser M; Brun R
Antimicrob Agents Chemother; 2009 Sep; 53(9):3815-21. PubMed ID: 19564359
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel 2,3-disubstituted quinoxaline derivatives as antileishmanial and antitrypanosomal agents.
Cogo J; Kaplum V; Sangi DP; Ueda-Nakamura T; Corrêa AG; Nakamura CV
Eur J Med Chem; 2015 Jan; 90():107-23. PubMed ID: 25461316
[TBL] [Abstract][Full Text] [Related]
13. Novel quinoline derivatives with broad-spectrum antiprotozoal activities.
Hartman CB; Dube PS; Legoabe LJ; Van Pelt N; Matheeussen A; Caljon G; Beteck RM
Arch Pharm (Weinheim); 2024 Jun; 357(6):e2300319. PubMed ID: 38396284
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
[TBL] [Abstract][Full Text] [Related]
15. Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana.
Urbina JA; Concepcion JL; Rangel S; Visbal G; Lira R
Mol Biochem Parasitol; 2002; 125(1-2):35-45. PubMed ID: 12467972
[TBL] [Abstract][Full Text] [Related]
16. In vitro screening of traditional South African malaria remedies against Trypanosoma brucei rhodesiense, Trypanosoma cruzi, Leishmania donovani, and Plasmodium falciparum.
Mokoka TA; Zimmermann S; Julianti T; Hata Y; Moodley N; Cal M; Adams M; Kaiser M; Brun R; Koorbanally N; Hamburger M
Planta Med; 2011 Sep; 77(14):1663-7. PubMed ID: 21412695
[TBL] [Abstract][Full Text] [Related]
17. Effect of Isolated Proteins from
Katz S; Barbiéri CL; Soler FPM; Soares AM; Chavantes MC; Zamuner SR
Protein Pept Lett; 2020; 27(8):718-724. PubMed ID: 31994997
[TBL] [Abstract][Full Text] [Related]
18. Voacamine alters Leishmania ultrastructure and kills parasite by poisoning unusual bi-subunit topoisomerase IB.
Chowdhury SR; Kumar A; Godinho JLP; De Macedo Silva ST; Zuma AA; Saha S; Kumari N; Rodrigues JCF; Sundar S; Dujardin JC; Roy S; De Souza W; Mukhopadhyay S; Majumder HK
Biochem Pharmacol; 2017 Aug; 138():19-30. PubMed ID: 28483460
[TBL] [Abstract][Full Text] [Related]
19. A Nature-Inspired Design Yields a New Class of Steroids Against Trypanosomatids.
Aguilera E; Perdomo C; Espindola A; Corvo I; Faral-Tello P; Robello C; Serna E; Benítez F; Riveros R; Torres S; Vera de Bilbao NI; Yaluff G; Alvarez G
Molecules; 2019 Oct; 24(20):. PubMed ID: 31652542
[TBL] [Abstract][Full Text] [Related]
20. The isolation and characterization of a new snake venom cysteine-rich secretory protein (svCRiSP) from the venom of the Southern Pacific rattlesnake and its effect on vascular permeability.
Suntravat M; Cromer WE; Marquez J; Galan JA; Zawieja DC; Davies P; Salazar E; Sánchez EE
Toxicon; 2019 Jul; 165():22-30. PubMed ID: 31014961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
